Nghi Nguyen, MD

Peer-Reviewed Articles

1. Girod BJ, Nguyen NC. Prostatic Utricle Cysts as a Potential Pitfall in PSMA PET/CT Interpretation. Clin Nucl Med 49(9):e470-e472, 2024. e-Pub 2024. PMID: 38914051.
2. Anigati EM, Nguyen NC. Incidental Finding of Spindle Cell Sarcoma on 68 Ga-PSMA-11 PET/CT. Clin Nucl Med 49(8):e423-e424, 2024. e-Pub 2024. PMID: 38620001.
3. Nguyen, NC, Anigati, EM, Desai, NB, Oz, OK. Radioactive Iodine Therapy in Differentiated Thyroid Cancer. Seminars in Nuclear Medicine 54(4):488-496, 2024. e-Pub 2024. PMID: 38772827.
4. Sweet, C, Shmuel, N, Shoaf, JN, Stoecklein, M, Muthukrishnan, A, Stern, E, Nguyen, NC. A Pictorial Review of I-123 MIBG Imaging of Neuroblastoma Utilizing a State-of-the-Art CZT SPECT/CT System. Nuclear Medicine and Molecular Imaging 58(1):1-8, 2024. e-Pub 2024.
5. Sweet C, Shmuel N, Shoaf JN, Stoecklein M, Muthukrishnan A, Stern E, Nguyen NC. A Pictorial Review of I-123 MIBG Imaging of Neuroblastoma Utilizing a State-of-the-Art CZT SPECT/CT System. Nucl Med Mol Imaging 58(1):1-8, 2024. e-Pub 2024. PMID: 38250182.
6. Qi J, Nguyen NC. Potential Pitfall of Fluciclovine PET/CT in Castrate-Resistant Prostate Cancer With Adrenal Metastasis. Clin Nucl Med 47(12):1061-1062, 2022. e-Pub 2022. PMID: 36026595.
7. Vasireddi A, Nguyen NC. Sincalide-Stimulated Cholescintigraphy: A Retrospective Study and Proposal of a Modified Workflow. Clin Nucl Med 47(1):1-6, 2022. e-Pub 2022. PMID: 34874343.
8. Muthukrishnan A, Pakala T, Srinivas S, Nguyen N, Drappatz J, Snyderman C, Gorantla V, Bahary N. Off-label usage of Lu-177 DOTATATE therapy: Challenges and opportunities for the theranostician. J Nucl Med 62(Suppl. 1):2029, 2021.
9. Nguyen NC, Beriwal S, Moon CH, Furlan A, Mountz JM, Rangaswamy B. (18)F-FDG PET/MRI Primary Staging of Cervical Cancer: A Pilot Study with PET/CT Comparison. J Nucl Med Technol 48(4):331-335, 2020. e-Pub 2020. PMID: 32709671.
10. Nguyen NC, Moon CH, Beriwal S. 18F-Fluciclovine PET/MRI in a Patient With Squamous Cell Carcinoma of the Uterine Cervix Correlated With 18F-FDG PET/CT. Clin Nucl Med 45(10):802-804, 2020. e-Pub 2020. PMID: 32558719.
11. Nguyen NC, Moon CH, Mettenburg JM. Incidental Diagnosis of an Arachnoid Granulation on Ga-68 DOTATATE PET/MRI. Nucl Med Mol Imaging 54(5):264-266, 2020. e-Pub 2020. PMID: 33088358.
12. Nguyen NC, Moon CH, Muthukrishnan A, Furlan A. 68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review. Clin Nucl Med 45(9):e406-e410, 2020. e-Pub 2020. PMID: 32520493.
13. Nguyen NC, Molnar TT, Cummin LG, Kanal E. Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis. Radiology 296(1):122-130, 2020. e-Pub 2020. PMID: 32343210.
14. Nguyen NC, Muthukrishnan A, Mountz JM. Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence. Clin Nucl Med 45(1):e63-e64, 2020. e-Pub 2020. PMID: 31652158.
15. Nguyen NC, Vercher-Conejero J, Faulhaber P. Tumor volume delineation: A pilot study comparing a digital positron-emission tomography prototype with an analog positron-emission tomography system. World J Nucl Med 18(1):45-51, 2019. e-Pub 2019. PMID: 30774546.
16. Nguyen NC, Vejdani K. Multipurpose computed tomography window for fusion display with functional imaging. World J Nucl Med 17(3):145-150, 2018. e-Pub 2018. PMID: 30034277.
17. Nguyen NC, Osman MM. Normalized Subtraction of Serial Brain Magnetic Resonance Images and Fludeoxyglucose-Positron Emission Tomography Images for Tumor Treatment Monitoring: Case Report and Method Description. J Clin Imaging Sci 8:25, 2018. e-Pub 2018. PMID: 30034929.
18. Nguyen NC, Yee MK, Tuchayi AM, Kirkwood JM, Tawbi H, Mountz JM. Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study. Front Oncol 8:18, 2018. e-Pub 2018. PMID: 29520339.
19. Nguyen N, Khan M, Shah M. Primary B-cell lymphoma of the pelvic bone in a young patient: Imaging features of a rare case. Cancer Research Frontiers 3(1):51-55, 2017. e-Pub 2017.
20. Nguyen NC, Abhishek K, Nyon S, Farghaly HR, Osman MM, Reimers HJ. Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study. Ann Thorac Med 11(1):49-54, 2016. e-Pub 2016. PMID: 26933457.
21. Nguyen NC, Vercher-Conejero JL, Sattar A, Miller MA, Maniawski PJ, Jordan DW, Muzic RF Jr, Su KH, O'Donnell JK, Faulhaber PF. Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET. J Nucl Med 56(9):1378-85, 2015. e-Pub 2015. PMID: 26159588.
22. Paspulati RM, Partovi S, Herrmann KA, Krishnamurthi S, Delaney CP, Nguyen NC. Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging 40(6):1415-25, 2015. e-Pub 2015. PMID: 26112492.
23. Vejdani K, Geller T, Nguyen N. Cerebral FDG metabolic pattern in pediatric patients with neurofibromatosis type 1: A retrospective study. Society of Nuclear Medicine:154, 2014. e-Pub 2014.
24. Allam T, Muzaffar R, Nguyen NC, Osman MM. Peritoneal Mouse as Detected on (18)F-FDG PET-CT. Front Oncol 3:83, 2013. e-Pub 2013. PMID: 23596568.
25. Mansouri AM, Vejdani K, Bastani B, Nguyen NC. Calculation of renal differential function following renal transplant: retrospective validation of a simplified method. Clin Nucl Med 37(10):931-8, 2012. e-Pub 2012. PMID: 22955066.
26. Aygen M, Amirmokri P, Berk F, Nguyen N, Bastani B, Civelek AC. A preliminary report on (99m)Tc-fanolesomab imaging of renal allograft. Nucl Med Commun 32(10):925-8, 2011. e-Pub 2011. PMID: 21862945.
27. Muzaffar R, Kudva G, Nguyen NC, Osman MM. Incidental diagnosis of thrombus within an aneurysm on 18F-FDG PET/CT: frequency in 926 patients. J Nucl Med 52(9):1408-11, 2011. e-Pub 2011. PMID: 21816969.
28. Osman MM, Altinyay ME, Abdelmalik AG, Brickman TM, Varvares MA, Nguyen NC. FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer. Clin Nucl Med 36(6):496-7, 2011. e-Pub 2011. PMID: 21552038.
29. Nguyen NC, Kaushik A, Wolverson MK, Osman MM. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncol 50(5):670-7, 2011. e-Pub 2011. PMID: 21247262.
30. Abdelmalik AG, Fajnwaks P, Osman MM, Nguyen NC. Squamous cell carcinoma of the bulbar conjunctiva seen on F-18 FDG PET/CT. Clin Nucl Med 35(12):962-4, 2010. e-Pub 2010. PMID: 21206233.
31. Osman MM, Chaar BT, Muzaffar R, Oliver D, Reimers HJ, Walz B, Nguyen NC. 18F-FDG PET/CT of patients with cancer: comparison of whole-body and limited whole-body technique. AJR Am J Roentgenol 195(6):1397-403, 2010. e-Pub 2010. PMID: 21098201.
32. Huston SF, Abdelmalik AG, Nguyen NC, Farghaly HR, Osman MM. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid. J Nucl Med Technol 38(3):123-7, 2010. e-Pub 2010. PMID: 20724533.
33. Moinuddin A, Nguyen NC, Osman MM. Careful evaluation of CT findings of a cardiac viability F-18 FDG PET/CT study leading to detection of esophageal cancer. Clin Nucl Med 35(5):335-7, 2010. e-Pub 2010. PMID: 20395707.
34. Sayed MH, Farghaly HR, Nguyen N, Mostafa MS, Mekkawy MA, Osman MM. Extrapulmonary small cell carcinoma in prostate: Detection with 18F-FDG PET/CT. Clin Nucl Med, 2010. e-Pub 2010. PMID: 20026974.
35. Nguyen N, Hueser C, Kaushik A, Farghaly HR, Osman MM. F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report, 2010. e-Pub 2010.
36. Nguyen N, Tran I, Hueser CN, Oliver D, Farghaly HR, Osman M. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: A retrospective study. Clin Nucl Med, 2009. e-Pub 2009. PMID: 20139823.
37. Nguyen N, Akduman E, Sayed M, Oliver D, Osman M. Increased F-18 FDG uptake in the posterior ocular bulb is associated with brain metastasis: A retrospective study. AJR Am J Roentgenol, 2008. e-Pub 2008. PMID: 19020214.
38. Hueser C, Nguyen N, Osman M, Havlioglu N, Patel AJ. Extrapulmonary small cell carcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans. World J Surg Oncol, 2008. e-Pub 2008. PMID: 18817561.
39. Nguyen N, Sayed MM, Taalab K, Osman MM. Spinal cord metastases from lung cancer: Detection with F-18 FDG PET/CT. Clin Nucl Med, 2008. e-Pub 2008. PMID: 18431157.
40. Nguyen N, Chaar BT, Osman M. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imaging, 2007. e-Pub 2007. PMID: 18076764.
41. Fenchel M, Helber U, Simonetti O, Stauder N, Kramer U, Nguyen N, Finn JP, Claussen C, Miller S. Multislice first-pass myocardial perfusion imaging: Comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. J Magn Reson Imaging, 2004. e-Pub 2004. PMID: 15112304.

Abstracts

1. Berning AW, Muthukrishnan M, Nguyen N. Sincalide-stimulated Cholescintigraphy: Continued validation of previously proposed modified workflow in a pediatric population. 2024 Annual SNMMI meeting, 2024.
2. Frankl J, Öz OK, Xi Y, Nguyen N. Primary lesion Ga-68 PSMA-11 total lesion activity (TLA) is a highly sensitive predictor with high negative predictive value of advanced stage in initial staging of patients with moderate to high-risk prostate cancer. Annual SNMMI meeting, 2024.
3. Girod BJ, Heglin AM, Angati E, Cheung JQ, Öz OK, Nguyen N. Lu-177 PSMA-617 radioligand therapy in prostate cancer – A review of current and new clinical trials. SNMMI - Southwestern Chapter meeting, 2024.
4. Luo J, Arefan D, Vasereddi A, Wu S, Nguyen N. Potential Use of Artificial Intelligence in Sincalide-Stimulated Cholescintigraphy: A Pilot Study. J Nucl Med 64(Suppl. 1):1119, 2023.
5. Sweet C, Shoaf JN, Stoecklein S, Ashok Muthukrishnan, Nguyen N. A pictorial review of I-123 MIBG imaging in pediatric neuroblastoma utilizing the state-of-the-art CZT SPECT/CT system. J Nucl Med 64(Suppl 1):2033, 2023.
6. Qi J, Chekuri S, Aginati E, Nguyen N. Ga-68 PSMA-11 PET/CT: Review of physiologic uptake and non-prostatic conditions. 67th Southwestern Chapter Annual Meeting, 2023.
7. Anigati E, Nguyen N, Öz OK. Unusual cases of contralateral sentinel lymph node in patients with breast cancer. 67th Southwestern Chapter Annual Meeting, SNMMI, 2023.
8. Chekuri S, Aginati E, Qi J, Nguyen N. Radioactive iodine therapy for differentiated thyroid cancer: An update on RAI dose determination and risk of secondary malignancies. 67th Southwestern Chapter Annual Meeting, 2023.
9. Öz OK, Kandathil A, Peng F, Kottwitz J, Nguyen N, Moore W. Initial Experience with Lu-177 Vipivotide Tetraxetan (Pluvicto). 67th Southwestern Chapter Annual Meeting, SNMMI, 2023.
10. Berning AW, Vasereddi A, Muthukrishnan A, Nguyen N. Sincalide-stimulated Cholescintigraphy: Validation of previously proposed modified workflow. J Nucl Med 64(Suppl. 1):1041, 2023.
11. Vasireddi A, Nguyen N. Sincalide-stimulated cholescintigraphy: A retrospective study and proposal of a modified workflow. J Nucl Med 61(Suppl. 1):421, 2020.
12. Patel AK, Olson, Nguyen N. Impact of Fluciclovine (18F) PET/CT on management of patients with suspected prostate cancer recurrence. ASTRO Annual Meeting, 2019.
13. Mertel K, Mohammadi S, Nguyen N, Mountz J, Muthukrishnan A. Utility of somatostatin receptor-targeted imaging with Ga-68 DOTATATE PET/MRI in the management of progressive meningiomas. J Nucl Med 59(Suppl. 1):1844, 2018.
14. Schoenbrun LE, Muthukrishnan A, Furlan A, Moon CH, Nguyen N. A pictorial review of Ga-68 DOTATATE PET/MRI for neuroendocrine neoplasm. J Nucl Med 59(Suppl. 1):1186, 2018.
15. Nguyen N, Beriwal S, Moon CH,, Furlan A, Rangaswamy B. Initial FDG PET/MR experience in cervical & uterine cancer staging: A pilot study. ISMRM-SNMMI co-provided workshop on PET/MRI. ISMRM-SNMMI, 2017.
16. Nguyen N, Tuchayi A, Yee M, Oborski M, Kirkwood J, Tawbi H, Mountz J. Targeted therapy and immunotherapy response assessment with F-18 FLT PET in melanoma brain metastasis (MBM). J Nucl Med 58(Suppl. 1):1289, 2017.
17. Nguyen N, Paspulati R, Herrmann KA. Role of PET-MR in assessment of tumor response in gastrointestinal and gynecological malignancies. RSNA 2014 Annual Meeting. Educational Exhibit, NME131, 2014.
18. Nguyen N, Faulhaber P, Paspulati R. Added Value of FDG PET/MRI compared with PET/CT in patients with colorectal cancer and workflow solutions for PET/MRI examination. RSNA 2014 Annual Meeting. Educational Exhibit, NME113, 2014.
19. Nguyen N, Vercher-Conejero J, Faulhaber P. Tumor volume delineation using a digital PET prototype: Initial clinical experience and comparison with analog PET. J Nucl Med 55(Suppl. 1):2160, 2014.
20. Nguyen N, Vercher-Conejero J, Faulhaber P. Brain imaging of neurological disorders using a digital PET prototype: Initial clinical experience and comparison with analog PET. J Nucl Med 55(Suppl. 1):206, 2014.
21. Rubbert C, Vercher-Conejero JL, Nguyen N, Wenzel F, Steinbach O, O'Donnell JK. Voxel-wise statistical testing of FDG-PET/CT: Impact on differential diagnosis of dementia. RSNA 2014, Scientific Poster, 2014.
22. Nguyen N, Partovi S, Herrmann K, Paspulati R. Added value of hybrid FDG PET/MR compared with PET/CT in colorectal cancer staging and restaging: Our initial experience. J Nucl Med 55(Suppl. 1):578, 2014.
23. Nguyen N, Vercher-Conejero J, O'Donnell J, Sattar A, Faulhaber P. Diagnostic performance of a digital PET prototype in patients with oncologic diagnosis: Initial clinical experience and comparison with analog PET. RSNA 2014 Annual Meeting, 2014.
24. Hu L, Stehning C, Nguyen N, Andrew Sher, Rios CM, Hu Z, Shao L. MR based PET attenuation correction (MRAC) and anatomical localization of human brain using an optimized UTE mDixon pulse sequence. 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2014.
25. Nguyen N, Vercher-Conejero J, ODonnell J, Sattar A, Faulhaber P. Image quality of a digital PET prototype: Initial clinical experience and comparison with analog PET. J Nucl Med 55(Suppl. 1):659, 2014.
26. Hemstock T, Botkin C, Hubble W, Osman M, Nguyen N. 123 I-Ioflupane: A new and promising tracer for Parkinson’s disease. J Nucl Med 53(Suppl. 1):2706, 2012.
27. Nyon S, Abhishek K, Abdelmalik A, Osman M, Nguyen N. Is the prognosis different between lung cancer with and without cavitary feature? A retrospective FDG PET/CT study. J Nucl Med 53(Suppl. 1):1392, 2012.
28. Vejdani K, Nguyen N. Chemotherapy for lymphoma in children does not affect cerebral glucose metabolism in the early post-treatment phase up to 6 months. J Nucl Med 53(Suppl. 1):2201, 2012.
29. Fajnwaks P, Abdelmalik A, Muzaffar R, Osman M, Nguyen N. Demonstration of active osteoarthropathy at In-111 Zevalin scan in a patient with non-Hodgkin’s lymphoma. J Nucl Med 52(Suppl. 1):1067, 2011.
30. Vu JT, Bhatla D, Abhishek K, Fajnwak P, Osman M, Nguyen N. Prevalence of acute pulmonary opacities following chemotherapy for lymphoma: A retrospective FDG PET/CT Study. 97th Scientific Assembly and Annual Meeting Program, 2011.
31. Almardoof A, Altinyay M, Yost P, Osman M, Nguyen N. FDG dose reduction in pediatric oncology correlated with EANM procedure guidelines - A case series. J Nucl Med 52(Suppl 1):1392, 2011.
32. Al-Mardoof AO, Abdelmalik A, Osman MM, Nguyen N. Characterization of extra-axial brain lesions using MRI versus co-registered FDG PET. Eur J Nucl Med Mol Imaging, 2011.
33. Ameen AM, Dombrowski J, Walz BJ, Dawson J, Naunheim K, Matsuo H, Osman MM, Nguyen N. Local recurrence after Cyberknife stereotactic body radiotherapy to non-small cell lung cancer – retrospective evaluation of predictive factors. Ninth Annual Cyberknife Scientific Meeting, 2010.
34. Muzaffar R, Osman MM, Abdelmalik AG, Fajnwaks P, Nguyen N. Protective value of intramural thrombus in the abdominal aortic aneurysm: metabolic changes as detected by FDG PET/CT. J Nucl Med 51(Suppl. 2):364, 2010.
35. Abdelmalik AG, Farghaly HR, Nassif AS, Nelson AS, MM Osman, Nguyen N. Do periventricular white matter hyperintensities as seen on MRI effect cerebral glucose metabolism? A retrospective study. Eur J Nucl Med Mol Imaging 37(Suppl. 2):320, 2010.
36. Altinyay ME, Touma W, Oliver D, Abdelmalik AG, Muzaffar R, Nguyen N, Osman MM. Metabolic characterization of untreated lung adenocarcinoma with 18F-FDG PET/CT: Impact of smoking. J Nucl Med 51(Suppl. 2):330, 2010.
37. Farghaly H, Abdelmalik A, Piper JW, Nelson AS, Osman MM, Nguyen N. Cerebral FDG PET - Comparison of Z-scores between single brain atlas and probalistic atlas. J Nucl Med 51(Suppl 2):242, 2010.
38. Collier T, Oliver D, Botkin C, Nguyen N, Osman MM. Should liver SUV still be used as an internal reference in the presence of benign liver disease?. J Nucl Med 51(Suppl. 2):413, 2010.
39. Farghaly HR, Muzaffar R, Bohle RJ, Nguyen N, Osman MM. Patterns and prevalence of misregistration in F-18 FDG PET/CT. Egyptian J. Nucl Med 2(2):55, 2009. e-Pub 2009.
40. Hueser CN, Tran I, Kaushik A, Farghaly HR, Sterkel B, Osman MM, Nguyen N. Lung cancer staging with FDG PET/CT: Does the Veterans Affairs (VA) population have unfavorable clinical features compared with the non-VA population? ASTRO’s 11 |N g h i C . N g u y e n Translational Advances in Radiation Oncology and Cancer Imaging Symposium. Cancer Imaging Symposium, 2009.
41. Karsch H, Muzaffar R, Botkin C, Nguyen N, Osman MM. Incidental diagnosis of prostate cancer in FDG PET/CT: Frequency in 1420 patients. J Nucl Med 50(Suppl. 2):446, 2009.
42. Krumrey S, Frye R, Tran I, Yost P, Nguyen N, Osman MM. FDG manual injection versus infusion system: A comparison of dose precision and extravasation. J Nucl Med 50(Suppl 2):430, 2009.
43. Farghaly HR, Osman MM, Piper JW, Nelson AS, Nguyen N. Cerebral FDG PET - correlation of asymmetry indices and differential Z-scores in healthy volunteers. 95th Scientific Assembly and Annual Meeting Program, 2009.
44. Farghaly HR, Greenwood T, Kaushik A, Frye R, Piper J, Osman MM, Abdulrauf SI, Nguyen N. Cerebral perfusion SPECT - comparison of three different interpretation approaches. J Nucl Med 50(Suppl. 2):243, 2009.
45. Farghaly HR, Piper J, Nelson AS, Osman MM, Nguyen N. Cerebral FDG PET/CT - validation of Z-scores using healthy controls from our institution. Eur J Nucl Med Mol Imaging(Suppl. 2):406, 2009.
46. Farghaly HR, Dombrowski J, Nassif AS, Nelson AS, Piper JW, Nguyen N. Potential use of normalized subtraction of serial brain FDG PET scans to evaluate for post-treatment brain changes. 95th Scientific Assembly and Annual Meeting Program, 2009.
47. Muzaffar R, Nguyen N, Osman MM, Farghaly HR, Oliver D, Wolverson MK. Incidental diagnosis of thrombus within an aneurysm in FDG PET/CT: Frequency in 926 patients. J Nucl Med 50(Suppl. 2):256, 2009.
48. Kaushik A, Farghaly HR, Abdelmalik A, Muzaffar R, Osman MM, Nguyen N. Oncological FDG PET/CT: Is there a universal SUV or lesion-to-liver SUV ratio?. J Nucl Med 50(Suppl. 2):30, 2009.
49. Nguyen N, Farghaly HR, Powell ED, Ojile JM, Muehlbach MJ, Uhles ML, Moinuddin A, Taalab K, Osman MM. Asymmetrical cerebral FGD metabolism in restless legs syndrome: A novel study during symptomology, 2009.
50. Tran I, Moinuddin A, Krumrey S, Frye R, Yost P, Nguyen N, Osman MM. Respiratory gating in FDG PET/CT: A Technologist's perspective. J Nucl Med 50(Suppl 2):428, 2009.
51. Abdelmalik A, Kaushik A, Muzaffar R, Farghaly HR, Osman MM, Nguyen N. Update on diagnostic accuracy of V/Q scan for the diagnosis of pulmonary embolism. 95th Scientific Assembly and Annual Meeting Program, 2009.
52. Farghaly HR, Stout J, Bucholz RR, Kaushik A, Osman MM, Nguyen N. Seizure diagnosis using multimodality imaging of MEG, MRI, PET and SPECT. 95th Scientific Assembly and Annual Meeting Program, 2009.
53. Kumar N, Kaushik A, Ruppel GL, Tran I, Farghaly HR, Osman MM, Nguyen N. Effect of hypoxia on SUV in patients with NSCLC - retrospective comparison between hypoxic and normoxic patients. J Nucl Med 50(Suppl. 2):355, 2009.
54. Qazi F, Oliver D, Nguyen N, Osman MM. Fatty liver: Impact on metabolic activity as detected with 18F FDG-PET/CT 49(Suppl 1):263, 2008.
55. Bohle R, Botkin C, Oliver D, Nguyen N, Osman MM. Effects of blood glucose levels on SUV. J Nucl Med 49(Suppl. 1):429, 2008.
56. MA Varvares, Wehrmann DJ, Amine M, Oliver DS, Odell MJ, Nguyen N, Osman MM. PET-CT in the management of head and neck malignancies: Clinical correlation improves accuracy of interpretation. 7th International Conference of Head and Neck Cancer, 2008.
57. Krumrey SA, Tran I, Yost P, Oliver D, Nguyen N, Osman M. Should FDG dose be based on BMI instead of body weight?. J Nucl Med 49(Suppl. 1):415, 2008.
58. Frye R, Yost P, Nguyen N, Osman MM. Tumor-to-liver uptake ratio .. comparison of visual with semi-quantitative evaluation. J Nucl Med 49(Suppl. 1):415, 2008.
59. Taalab K, Rios T, Nguyen N, Cummings J, Oliver D, Osman MM. Utility of FDG PET/CT in staging and restaging of prostate cancer, 2008.
60. Nguyen N, Nassif AS, Sayed MH, Osman MM. Characterization of brain lesions using MRI/spectroscopy versus FDG PET fused with MRI. J Nucl Med 49(Suppl. 1):223, 2008.
61. Nguyen N, Farghaly HR, Nassif S, Sayed MH, Osman MM. Characterization of brain lesions using MRI without/with spectroscopy versus FDG PET fused with MRI. Scientific Assembly and Annual Meeting Program, 2008.
62. Lees M, Dombrowski J, Botkin C, Hubble W, Nguyen N, Osman MM. Utilization of Na22 PET markers in radiation therapy planning: Initial experience. J Nucl Med 49(Suppl. 1):223, 2008.
63. Sayed MH, Nguyen N, Oliver DS, Naunheim KS, Bucholz RD, Walz BJ, Osman MM. Response to Cyberknife stereotactic radiosurgery as detected with 18F FDG- PET/CT: Initial Experience. J Nucl Med 49(Suppl. 1):146, 2008.
64. Tran IT, Yost P, Oliver D, Nguyen N, Osman MM. 18F-FDG PET/CT of obese patients: Prevalence, challenges, and solutions. J Nucl Med 49(Suppl. 1):415, 2008.
65. Kaushik A, MM Osman, Oliver D, Varvares M, Nguyen N. Role of F-18 FDG PET/CT in staging of head and neck cancer, 2008.
66. Mueller T, Botkin C, Oliver D, Nguyen N, Osman MM. Prevalence of abnormal blood glucose levels in patients undergoing FDG PET/CT scan. J Nucl Med 49(Suppl. 1):429, 2008.
67. Nguyen N, Tran I, Sayed MH, Oliver D, Williamson M, Osman MM. Combined F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes: An initial experience. Joint Molecular Imaging Conference:341, 2007.
68. Nguyen N, Taalab K, Sayed MH, Oliver D, Williamson M, Reimers HJ, Osman MM. Combined F-18 FDG PET/CT characterization of cavitary lung lesions and comparison of cavitary to non-cavitary lung carcinoma. Joint Molecular Imaging Conference:225, 2007.
69. Nguyen N, Sayed MH, Akduman I, Oliver D, Osman MM. Pattern and prevalence of increased F-18 FDG uptake at the posterior ocular bulb in seizure patients: An initial study. Eur J Nucl Med Mol Imaging 34(Suppl):S320, 2007.
70. Nguyen N, Oliver D, Taalab K, Sayed MH, Williamson M, Reimers HJ, Ravindra V, Osman MM. Characterization of indeterminate pulmonary nodules with F-18 FDG PET/CT: An initial experience. Joint Molecular Imaging Conference:225, 2007.
71. Nguyen N, Oliver D, El-Sadda W, Osman MM. Does asymmetric cerebellar FDG uptake have added value in the diagnosis of brain metastasis? A semiquantitative evaluation with FDG PET/CT. Eur J Nucl Med Mol Imaging 34(Suppl 2):S401, 2007.
72. Williamson Jr. MJ, Nguyen N, Reimers HJ, Naunheim KS, Osman MM. Prevalence and patterns of post-solid organ transplant malignancies as detected by F-18 FDG PET and PET/CT. Eur J Nucl Med Mol Imaging 33(Suppl. 2):S202, 2006.
73. Aygen M, Bastani B, Amirmokri P, Berk F, Nguyen N, Civelek AC. Use of Tc-99m-fanolesomab scans for evaluation of vascular access site infection in dialysis patients 47(Suppl 1):151, 2006.
74. Nguyen N, Hogan ER, El-Sadda W, Oliver D, Osman MM. Comparison of SUV of the pons and cerebellum in F-18 FDG PET/CT: Pons is a better internal reference point. J Nucl Med 47(Suppl 1):301, 2006.
75. Nguyen N, El-Sadda W, Akduman I, Oliver D, Ege G, Osman MM. PET/CT characterization of adrenal lesions 47(Suppl 1):226, 2006.
76. Nguyen N, Hogan ER, Aygen M, Civelek CA, Osman MM. Increased F-18 FDG uptake in the posterior ocular bulb may indicate brain metastases: An initial study 47(Suppl 1):303, 2006.
77. Aygen M, Amirmokri P, Berk F, Nguyen N, Civelek AC, Bastani B. A prilimary report on NeutroSpec imaging of renal allograft. J Nucl Med 47(Suppl 1):360, 2006.
78. Oliver D, Miller MD, Nguyen N, Walz BJ, Bucholz R, Osman MM. Added value of F-18 FDG-PET/CT in Cyberknife stereotactic radiosurgery for extracranial lesions. Fifth Annual Cyberknife Scientific Meeting, 2006.
79. Nguyen N, Cooper MH, Oliver D, Osman MM. Comparison of SUV of the pons and cerebellum in the presence of crossed cerebellar diaschisis and anatomical localization of pontine glucose metabolic activity with 18F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 33(Suppl. 2):S289, 2006.
80. Osman MM, Nguyen N, Oliver D.. PET/CT Characterization of adrenal glands in normal volunteers using F-18 FDG. J Nucl Med 33(Suppl. 2):263, 2006.
81. El-Sadda W, Nguyen N, Varvaras MA, Osman MM. Added value of F-18 FDG-PET/CT in patients with head and neck cancer: Detection of distant metastases and second primary cancers. J Nucl Med 47(Suppl 1):468, 2006.
82. Nguyen N, Hussein M, Osman MM. Prevalence and patterns of soft tissue metastases: Detection with true whole-body F-18 FDG PET/CT. J Nucl Med 46(Suppl 2):234, 2005.
83. Nguyen N, Osman MM. Added value of true whole-body over limited whole-body FDG-PET/CT in cancer imaging. J Nucl Med 46(Suppl 2):236, 2005.
84. Nguyen N, Dittmann H, Hundt I, Bares R. Attenuation correction in myocardial perfusion-SPECT: First clinical experience with a dual-head gamma camera mounted x-ray tube(43), 2004.
85. Schöbel WA, Leinweber M, Nguyen N, Gellen B, Karsch KR. Downregulation of the death-promoting protein bax following experimental vessel wall injury.
86. Schöbel WA, Leinweber M,, Nguyen N, Gellen B. Reduced expression of the apoptose-agonist bax following experimental vessel wall injury.

Book Chapters

1. Nguyen, NC, Chekuri, S, Oz, OK. Nuclear Medicine in the Diagnosis and Management of Thyroid Nodules and Cancer, 81-128, 2024.
2. Nguyen N, Shah M, Appleman L, Parikh R, Mountz JM. Radium-223 therapy for patients with metastatic castrate-resistant prostate cancer: An update on literature with case presentation. Int J. Mol Imaging.
3. Nguyen N, Chekuri S, Öz OK.. Nuclear Medicine Imaging and Therapy of Thyroid Nodules and Cancer. In: Thyroid Radiofrequency Ablation. Springer.
4. Nguyen N, Beriwal S, Moon CH, D'Ardenne N, Mountz JM, Furlan A, Muthukrishnan A, Rangaswamy B. Diagnostic value of FDG PET/MRI in females with pelvic malignancy – a systematic review of the literature.
5. Osman MM, Varvares MA, Nguyen N. Pictorial essay: Nonmalignant FDG uptake in the head and neck regions. In: PET Clinics. 4. Elsevier, 445 - 468.
6. Nguyen N, Akduman I, Osman MM. F-18 FDG PET and PET/CT imaging of cancer patients. In: Journal Of Radiology Nursing. Elsevier, 61 - 69.
7. Osman MM, Wall A, Miller MD, Nguyen N, Oliver DA, Bucholz RD, Walz BJ. 18 FDG-PET/CT for Treatment Planning and Follow-Up. In: Treatment Tumors That Move with Respiration. Springer, 55-61.
8. Nguyen N, Montagnese J, Rogers LR, Sher A, Wolansky L. Positron emission tomography/magnetic resonance imaging (PET/MRI) in the evaluation of brain tumors: Current status and future prospects. In: Seminars in Roentgenology. Elsevier.
9. Nguyen N, Vasireddi A. PET/CT Limitations and Pitfalls in Urogenital Cancers. Elsevier.

Letters to the Editor

1. Fesler MJ, Nguyen NC, Petruska PJ. Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma. Int J Hematol 92: 211-3, 2010.